| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2478353 | Annales Pharmaceutiques Françaises | 2011 | 15 Pages |
Abstract
The factors influencing the profile of meta-trajectories of CD4 cells count during efavirenz-based antiretroviral regimen should be considered at the initiation of treatment to optimize performance in the therapeutic monitoring of patients in Abidjan. The model of biomedical indicators meta-trajectories provides a therapeutic decision support provided prior to capitalize sufficient expertise for a better interpretation.
Keywords
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Drug Discovery
Authors
D.P. Abrogoua, G. Aulagner, B.J. Kablan, C. Petit,